WHF:NASDAQWhiteHorse Finance, Inc. Analysis
Data as of 2026-05-10 - not real-time
$7.68
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
WHF is trading at $7.68, just below its 20‑day SMA of 7.60 and comfortably above the 50‑day SMA of 7.38, indicating short‑term price stability. The 20‑day SMA also sits slightly under the 200‑day SMA of 7.42, suggesting the longer‑term trend remains neutral. RSI at 58.5 shows the stock is not overbought, while the MACD histogram is negative and the signal line is bearish, hinting at modest downside pressure. Technical support sits near $7.20 and resistance near $7.81, placing the current price within a narrow range. Volatility over the past 30 days is high at nearly 24 % and beta is low at 0.46, meaning price swings are pronounced but less correlated with the market. The latest earnings release disclosed a 17.5 % drop in revenue and credit‑related losses that eroded net asset value, though share repurchases helped cushion the impact.
On the valuation side, the trailing P/E of 18.73 exceeds the industry average of 16.39, but the forward P/E of 7.5 and a price‑to‑book of 0.66 point to a significant discount to intrinsic value. The dividend yield of 16.9 % is eye‑catching, yet the payout ratio of over 220 % raises serious sustainability concerns. With total debt of $324 million against a market cap of $166 million (debt‑to‑equity >124), the balance sheet is heavily leveraged, contributing to a max drawdown of roughly 35 %. Volume trends are decreasing, and analyst coverage is thin (only three analysts), adding to liquidity risk. Nevertheless, the company’s buyback program and a 35 % NAV discount provide a potential catalyst for price appreciation if credit conditions improve. Given the mix of high dividend allure, undervalued valuation metrics, but pronounced credit and liquidity headwinds, investors should approach WHF with caution and prioritize risk management.
On the valuation side, the trailing P/E of 18.73 exceeds the industry average of 16.39, but the forward P/E of 7.5 and a price‑to‑book of 0.66 point to a significant discount to intrinsic value. The dividend yield of 16.9 % is eye‑catching, yet the payout ratio of over 220 % raises serious sustainability concerns. With total debt of $324 million against a market cap of $166 million (debt‑to‑equity >124), the balance sheet is heavily leveraged, contributing to a max drawdown of roughly 35 %. Volume trends are decreasing, and analyst coverage is thin (only three analysts), adding to liquidity risk. Nevertheless, the company’s buyback program and a 35 % NAV discount provide a potential catalyst for price appreciation if credit conditions improve. Given the mix of high dividend allure, undervalued valuation metrics, but pronounced credit and liquidity headwinds, investors should approach WHF with caution and prioritize risk management.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD histogram
- Decreasing volume and neutral trend
- Credit‑related earnings drag
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Forward P/E of 7.5 indicating valuation upside
- Buyback support at NAV discount
- High dividend yield (cautiously)
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Elevated debt‑to‑equity and max drawdown risk
- Uncertain dividend sustainability
- Sector credit risk exposure
Key Metrics & Analysis
Financial Health
Revenue Growth-17.50%
Profit Margin19.73%
P/E Ratio18.7
ROE5.25%
ROA4.83%
Debt/Equity124.65
P/B Ratio0.7
Op. Cash Flow$77.3M
Free Cash Flow$4.5M
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI58.5
Support$7.20
Resistance$7.81
MA 20$7.60
MA 50$7.38
MA 200$7.42
MACDBearish
VolumeDecreasing
Fear & Greed Index90.73
Valuation
Target Price$7.67
Upside/Downside-0.17%
GradeUndervalued
TypeValue
Dividend Yield16.89%
Risk Assessment
Beta0.46
Volatility23.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.